Nature Reviews Drug Discovery

Nature Reviews Drug Discovery is a review journal with an emphasis on drug discovery and development. With an impact factor of 28.712 in 2010 it is the leading journal in pharmacology/pharmacy and biotechnology/applied microbiology areas. The reviews are commissioned to leaders in the their specialties (non-commissioned review submissions are discouraged), but are also peer-reviewed after submission. The reviews are supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal accepts peer-reviewed analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.

Publisher
Nature Publishing Group
Country
international
Website
http://www.nature.com/nrd/index.html
Impact factor
29.008 (2011)

Some content from Wikipedia, licensed under CC BY-SA

Medical research

Drug screens and CRISPR combine to help make better cancer drugs

A new study has created the most comprehensive analysis for understanding how cancer drugs work at a molecular level. Scientists at the Wellcome Sanger Institute, EMBL's European Bioinformatics Institute (EMBL-EBI) and AstraZeneca ...

Medications

How many rare diseases are there?

Some diseases are like black swans. They occur so rarely that many physicians never encounter them in their clinical practice, complicating efforts to treat them.

Medications

Scientists suggest new solution to the rare-disease problem

Thousands of rare diseases cumulatively affect millions of people across the globe, yet because each case is so rare doctors struggle to accurately diagnose and effectively treat individual patients. Every time a patient ...

Neuroscience

How to improve multiple sclerosis therapy

Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase. Many patients, however, develop progressive MS at a later stage, with disability becoming ...

Alzheimer's disease & dementia

Preventive treatment for Alzheimer's and Parkinson's disease

A diagnosis of Alzheimer's disease is devastating for those affected, as there is still no cure for this type of dementia. One hundred years after Alois Alzheimer first described it, we neither have a drug for it, nor do ...

Medications

Characteristics of international drug regulatory regimes

The regulatory requirements for the approval of new drugs vary greatly internationally in regards to the resources allocated to the authorities, the evaluation periods for approval and the fees for the pharmaceutical companies. ...

page 1 from 2